Joanna Gromadzka-Ostrowska Selected Research

(1-3)(1-4)- beta-glucan

1/2022	Colon Expression of Chemokines and Their Receptors Depending on the Stage of Colitis and Oat Beta-Glucan Dietary Intervention-Crohn's Disease Model Study.
8/2021	Clinical Outcomes after Oat Beta-Glucans Dietary Treatment in Gastritis Patients.
4/2021	Anti-Inflammatory Activity of Oat Beta-Glucans in a Crohn's Disease Model: Time- and Molar Mass-Dependent Effects.
4/2020	Time-Dependent Indirect Antioxidative Effects of Oat Beta-Glucans on Peripheral Blood Parameters in the Animal Model of Colon Inflammation.
10/2019	Beneficial Effects of Oat Beta-Glucan Dietary Supplementation in Colitis Depend on its Molecular Weight.
10/2019	Oral administration of oat beta-glucan preparations of different molecular weight results in regulation of genes connected with immune response in peripheral blood of rats with LPS-induced enteritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joanna Gromadzka-Ostrowska Research Topics

Disease

11	Inflammation (Inflammations) 01/2022 - 02/2008
5	Colitis 01/2022 - 10/2019
5	Body Weight (Weight, Body) 01/2022 - 01/2013
3	Crohn Disease (Crohn's Disease) 01/2022 - 01/2021
3	Enteritis 10/2019 - 02/2015
1	Cognitive Dysfunction 01/2022
1	Gastritis 08/2021
1	Carcinogenesis 02/2021
1	Prostatic Neoplasms (Prostate Cancer) 02/2021
1	Weight Gain 01/2021
1	Atherosclerotic Plaque (Atheroma) 11/2017
1	Lung Neoplasms (Lung Cancer) 11/2017
1	Lung Diseases (Lung Disease) 11/2017
1	Lung Injury 01/2017
1	Necrosis 01/2016
1	Obesity 01/2013
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2013
1	Cystitis 02/2008
1	Neoplasms (Cancer) 01/2006

Drug/Important Bio-Agent (IBA)

7	beta-GlucansIBA 01/2022 - 02/2015
6	(1-3)(1-4)- beta-glucanIBA 01/2022 - 10/2019
5	AntioxidantsIBA 01/2022 - 06/2018
2	ChemokinesIBA 01/2022 - 10/2019
2	SilverIBA 01/2022 - 01/2016
2	Sulfonic AcidsIBA 04/2021 - 04/2020
2	sym-trinitrobenzeneIBA 04/2021 - 04/2020
2	Interleukin-12 (IL 12)IBA 04/2021 - 02/2015
2	CytokinesIBA 04/2021 - 10/2019
2	Immunoglobulins (Immunoglobulin)IBA 01/2021 - 02/2008
2	Hormones (Hormone)IBA 01/2021 - 01/2006
2	SteroidsIBA 01/2017 - 01/2006
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Chemokine ReceptorsIBA 01/2022
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2022
1	IonsIBA 01/2022
1	Bovine Serum AlbuminIBA 01/2022
1	Citric Acid (Citrate)FDA LinkGeneric 01/2022
1	Glutathione (Reduced Glutathione)IBA 08/2021
1	Dinoprostone (PGE2)FDA Link 04/2021
1	Polysaccharides (Glycans)IBA 04/2021
1	Food IngredientsIBA 02/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2021
1	Trans Fatty AcidsIBA 02/2021
1	FertilizersIBA 01/2021
1	MineralsIBA 01/2021
1	dectin 1IBA 01/2021
1	Caspase 3 (Caspase-3)IBA 01/2021
1	Ethanol (Ethyl Alcohol)IBA 01/2020
1	Therapeutic UsesIBA 10/2019
1	PolymersIBA 10/2019
1	EicosanoidsIBA 10/2019
1	Vehicle Emissions (Emissions, Vehicle)IBA 11/2017
1	Messenger RNA (mRNA)IBA 01/2017
1	Androgen Receptors (Androgen Receptor)IBA 01/2017
1	Testosterone (Sustanon)FDA Link 01/2017
1	GlucansIBA 10/2016
1	DNA (Deoxyribonucleic Acid)IBA 01/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2015
1	Interleukin-10 (Interleukin 10)IBA 02/2015
1	Thiobarbituric Acid Reactive SubstancesIBA 02/2015
1	Triglycerides (Triacylglycerol)IBA 01/2013
1	LeptinIBA 01/2013
1	FuraginIBA 02/2008
1	Ciprofloxacin (Cipro)FDA LinkGeneric 02/2008
1	Interleukin-8 (Interleukin 8)IBA 02/2008
1	Nitrofurantoin (Macrodantin)FDA LinkGeneric 02/2008

Therapy/Procedure

1	Oral Administration 10/2019
1	Therapeutics 02/2008
1	Duration of Therapy 02/2008